Tag Archives: skyrocket

Deciphera shares skyrocket as cancer drug improves progression-free survival

(Reuters) – Deciphera Pharmaceuticals Inc’s shares more than doubled on Tuesday after the drugmaker said its late-stage study met the main goal of helping stomach cancer patients live longer without their disease worsening. The study tested the treatment, ripretinib, against placebo in 129 patients with advanced gastrointestinal stromal tumors (GIST), a rare cancer affecting the… Read More »